<DOC>
	<DOCNO>NCT00603798</DOCNO>
	<brief_summary>The purpose study determine whether imiquimod cream effective treat Actinic Keratoses apply face bald scalp . Actinic keratosis ( AK ) skin condition show skin routinely expose sun , face , scalp , shoulder , chest , back , arm , hand . The active ingredient contain study cream study approve product Aldara , show safe effective treatment AKs .</brief_summary>
	<brief_title>Safety Effectiveness Study Imiquimod Creams Treatment Actinic Keratoses ( AKs )</brief_title>
	<detailed_description>These randomize , double-blind , multicenter , placebo-controlled study compare efficacy safety 2.5 % imiquimod cream 3.75 % imiquimod cream placebo treatment typical visible palpable AK face bald scalp . Subjects schedule total 11 visit ( 1 prestudy screen visit 10 on-study visit ) . Subjects determine eligible screen phase randomize 1:1:1 ratio 2.5 % imiquimod cream , 3.75 % imiquimod cream , placebo cream . The cream apply daily 2 treatment cycle . The first treatment cycle consist 3 week daily treatment follow 3 week treatment , second treatment cycle consist additional 3 week daily treatment follow 8 week treatment . The investigator select treatment area study ( either entire face entire balding scalp , ) . Subjects apply thin layer cream treatment area ( 2 packet , 500 mg product , per application ) , avoid periocular area , lip , naris . Study medication apply prior normal sleeping hour remove approximately 8 hour later mild soap water . Ears exclude assessment treatment . Rest period daily treatment instituted investigator need manage local skin reaction ( LSRs ) application site reaction , resumption treatment upon adequate resolution determine investigator . The duration subject 's study participation approximately 21 week , include 4-week maximum screening period 17-week study period . At End Study ( EOS ) visit , eligible subject may invite participate separate study evaluate AK recurrence .</detailed_description>
	<mesh_term>Keratosis</mesh_term>
	<mesh_term>Keratosis , Actinic</mesh_term>
	<mesh_term>Imiquimod</mesh_term>
	<criteria>In good general health . Have 5 20 AKs face bald scalp . Negative pregnancy test ( woman able become pregnant ) . Willing make frequent visit study center treatment followup period . Women pregnant , lactate plan become pregnant study . Have medical event within 90 day first visit ( : stroke , heart attack ) . Have skin condition treatment area may make bad treatment imiquimod ( : rosacea , psoriasis , atopic dermatitis , eczema ) . Have receive specific treatments/medications treatment area ( ) within designated time period prior study treatment initiation .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2010</verification_date>
	<keyword>Actinic keratosis</keyword>
	<keyword>Dermatologic disease</keyword>
</DOC>